Milad Enferadi
Research Subjects
Milad Enferadi has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Mahdi Sadeghi
Medical Physics Department, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
18 shared publications Hojjat Nadi
Islamic Azad University
3 shared publicationsChuan-Jong Tung
A Department of Medical Imaging and Radiological Sciences, College of Medicine , Chang Gung University , Tao-yuan , Taiwan
2 shared publicationsH. Nadi
Islamic Azad University
2 shared publicationsParvin Sarabadani
Agricultural, Medical & Industrial Research School, Nuclear Science and Technology Research Institute
2 shared publications- Tsi-Chian Chao
Chang Gung Univ. (Taiwan)
2 shared publications
Latest Publications
- 1 January 2022
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 85, 222-227
MRI-based machine learning for determining quantitative and qualitative characteristics affecting the survival of glioblastoma multiforme
- 1 January 2022
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 85, 222-227
MRI-based machine learning for determining quantitative and qualitative characteristics affecting the survival of glioblastoma multiforme
- 27 October 2021
- Published by Wiley in Medical Physics
- Vol. 48 (12) , 7712-7724
The effect of magnetic field strength on the positron range and projected annihilation artifact in integrated PET/MR systems: A GATE Monte Carlo study
Purpose: With improvements in positron emission tomography/magnetic resonance imaging (PET/MRI) over the last decade, there is a need to investigate the projected annihilation (shine‐through) artifact and resolution impact for different PET radiopharmaceuticals, magnetic field (MF) strengths, and tissues.Methods: The GATE Monte Carlo (MC) simulation was used to simulate the annihilation distribution of positrons in different tissues and MFs. The positron distribution was studied in magnetic field (MF) intensities up to 15 T for 11C, 13N, 15O, 18F, 68Ga, and 82Rb. Moreover, the image quality in terms of the occurrence of projected annihilation artifacts was investigated using the 4D anthropomorphic digital extended cardiac‐torso (XCAT) phantom.Results: Positron ranges were restricted across the directions perpendicular to the MF, but no change along the direction of the MF was detected. The projected annihilation artifacts were observed with the presence of MF in the sagittal and coronal view of PET images prepared from the XCAT phantom. The intensity of artifact was constant in MFs higher than 3 T. The significant effect of the MF on resolution improvement was observed in soft tissue for 68Ga in 7 T and 82Rb in 3 and 7 T, while higher MFs have no impact on resolution. The improvement of resolution in the lung tissue was observed for the medium‐ and high‐energy radionuclides in 7 T MF.Conclusion: The MF can create the projected annihilation artifact in the boundary of air cavities and other tissues for medium‐ and high‐energy radionuclides especially for 68Ga in clinical studies. In addition, the strength of the MFs more than 3 T was ineffective on the intensity of the projected annihilation artifact. In a clinical PET/MR scanner, MF has remarkable spatial resolution improvement in lung tissue, especially for medium‐ and high‐energy radionuclides, and negligible effect in bone and soft tissue for most radionuclides.
- 27 October 2021
- Published by Wiley in Medical Physics
- Vol. 48 (12) , 7712-7724
The effect of magnetic field strength on the positron range and projected annihilation artifact in integrated PET/MR systems: A GATE Monte Carlo study
Purpose: With improvements in positron emission tomography/magnetic resonance imaging (PET/MRI) over the last decade, there is a need to investigate the projected annihilation (shine‐through) artifact and resolution impact for different PET radiopharmaceuticals, magnetic field (MF) strengths, and tissues.Methods: The GATE Monte Carlo (MC) simulation was used to simulate the annihilation distribution of positrons in different tissues and MFs. The positron distribution was studied in magnetic field (MF) intensities up to 15 T for 11C, 13N, 15O, 18F, 68Ga, and 82Rb. Moreover, the image quality in terms of the occurrence of projected annihilation artifacts was investigated using the 4D anthropomorphic digital extended cardiac‐torso (XCAT) phantom.Results: Positron ranges were restricted across the directions perpendicular to the MF, but no change along the direction of the MF was detected. The projected annihilation artifacts were observed with the presence of MF in the sagittal and coronal view of PET images prepared from the XCAT phantom. The intensity of artifact was constant in MFs higher than 3 T. The significant effect of the MF on resolution improvement was observed in soft tissue for 68Ga in 7 T and 82Rb in 3 and 7 T, while higher MFs have no impact on resolution. The improvement of resolution in the lung tissue was observed for the medium‐ and high‐energy radionuclides in 7 T MF.Conclusion: The MF can create the projected annihilation artifact in the boundary of air cavities and other tissues for medium‐ and high‐energy radionuclides especially for 68Ga in clinical studies. In addition, the strength of the MFs more than 3 T was ineffective on the intensity of the projected annihilation artifact. In a clinical PET/MR scanner, MF has remarkable spatial resolution improvement in lung tissue, especially for medium‐ and high‐energy radionuclides, and negligible effect in bone and soft tissue for most radionuclides.
- 8 January 2018
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 94 (2) , 124-136
Radiosensitization of ultrasmall GNP–PEG–cRGDfK in ALTS1C1 exposed to therapeutic protons and kilovoltage and megavoltage photons
Purpose: One of the promising radiosensitizers is the ultrasmall gold nanoparticle (GNP) with a hydrodynamic diameter vβ3) in the murine ALTS1C1 glioma cell line. Materials and methods: We investigated the uptake, toxicity and radiosensitivity of GNP–PEG–cRGDfKs in ALTS1C1 cells exposed to protons, kilovoltage photons and megavoltage photons. The in vitro uptake and toxicity of GNPs in the hepatocytes and Kupffer cells were assessed for murine AML12 hepatocyte and RAW 264.7 macrophage cell lines. The in vivo biodistribution of GNPs in the ALTS1C1 tumor model was tested using the inductively coupled plasma mass spectrometry. Results: Results indicated GNPs accumulated in the cytoplasm with negligible toxicity for a moderate concentration of GNPs. Observed sensitizer enhancement ratios and dose enhancement factors are 1.21–1.66 and 1.14–1.33, respectively, for all radiations. Conclusion: Ultrasmall GNP–PEG–cRGD can be considered as a radiosensitizer. For radiotherapy applications, the delivery method should be developed to increase the GNP uptake in the tumor and decrease the uptakes in undesirable organs.
- 8 January 2018
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 94 (2) , 124-136
Radiosensitization of ultrasmall GNP–PEG–cRGDfK in ALTS1C1 exposed to therapeutic protons and kilovoltage and megavoltage photons
Purpose: One of the promising radiosensitizers is the ultrasmall gold nanoparticle (GNP) with a hydrodynamic diameter vβ3) in the murine ALTS1C1 glioma cell line. Materials and methods: We investigated the uptake, toxicity and radiosensitivity of GNP–PEG–cRGDfKs in ALTS1C1 cells exposed to protons, kilovoltage photons and megavoltage photons. The in vitro uptake and toxicity of GNPs in the hepatocytes and Kupffer cells were assessed for murine AML12 hepatocyte and RAW 264.7 macrophage cell lines. The in vivo biodistribution of GNPs in the ALTS1C1 tumor model was tested using the inductively coupled plasma mass spectrometry. Results: Results indicated GNPs accumulated in the cytoplasm with negligible toxicity for a moderate concentration of GNPs. Observed sensitizer enhancement ratios and dose enhancement factors are 1.21–1.66 and 1.14–1.33, respectively, for all radiations. Conclusion: Ultrasmall GNP–PEG–cRGD can be considered as a radiosensitizer. For radiotherapy applications, the delivery method should be developed to increase the GNP uptake in the tumor and decrease the uptakes in undesirable organs.
- 10 October 2017
- Published by Springer Nature in Journal of Radioanalytical and Nuclear Chemistry
- Vol. 314 (2) , 1207-1235
Nuclear reaction cross sections for proton therapy applications
- 10 October 2017
- Published by Springer Nature in Journal of Radioanalytical and Nuclear Chemistry
- Vol. 314 (2) , 1207-1235
Nuclear reaction cross sections for proton therapy applications
- 1 March 2013
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 73, 109-115
Dosimetric aspects of 166Ho brachytherapy biodegradable glass seed
- 1 March 2013
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 73, 109-115
Dosimetric aspects of 166Ho brachytherapy biodegradable glass seed
- 1 March 2012
- Published by Elsevier in Annals of Nuclear Energy
- Vol. 41, 97-103
Accelerator production of the positron emitter zirconium-89
- 1 March 2012
- Published by Elsevier in Annals of Nuclear Energy
- Vol. 41, 97-103
Accelerator production of the positron emitter zirconium-89
- 1 November 2011
- Published by Bentham Science Publishers Ltd. in Current Cancer Therapy Reviews
- Vol. 7 (4) , 303-318
Radiation Therapy in the Early 21st Century: Technological Advances
Background: Today, cancer treatment is one of challenges in health and treatment system of any country. With quick development of radiation therapy and chemotherapy in recent years, this question is brought up that which method is more perfect to treat cancer. Methods: Radiation therapy is consisted of several methods including external radiation therapy (e.g. CyberKnife, IMRT, IGRT, SBRT, BNCT, Vero, IORT, Gamma knife, Tomotherapy and Volumetric modulated arc therapy (VMAT)) and internal radiation therapy (e.g. brachytherapy, endoradiotherapy (target radionuclide therapy): radioimmunotherapy and peptide receptor radionuclide therapy) that any one has a special function in cancerous cells destroy. Results: Chemotherapy has still its place in cancer treatment and is used as a current and worldwide method. Nowadays, radiation therapy evolves with a surprising growth. By abandoning Cobalt-60, linear and circular accelerators which are able to accelerate particles, could be used for cancer treatment. CyberKnife, IMRT, IGRT, SBRT, VMAT, tomotherapy and Vero are the most advanced methods used to radiation therapy in all angles which had minimum mistake in radiation to the near intact tissues. Today, brachytherapy by increasing production of treatment radioisotopes by cyclotron and reactor is used in the world. Endoradiotherapy (Target radionuclide therapy): Radioimmunotherapy and peptidereceptor radionuclide therapy are two considerable methods in cancer treatment. Conclusion: In this review, we consider principals and application of radiation therapy in the early 21st century.
- 1 November 2011
- Published by Bentham Science Publishers Ltd. in Current Cancer Therapy Reviews
- Vol. 7 (4) , 303-318
Radiation Therapy in the Early 21st Century: Technological Advances
Background: Today, cancer treatment is one of challenges in health and treatment system of any country. With quick development of radiation therapy and chemotherapy in recent years, this question is brought up that which method is more perfect to treat cancer. Methods: Radiation therapy is consisted of several methods including external radiation therapy (e.g. CyberKnife, IMRT, IGRT, SBRT, BNCT, Vero, IORT, Gamma knife, Tomotherapy and Volumetric modulated arc therapy (VMAT)) and internal radiation therapy (e.g. brachytherapy, endoradiotherapy (target radionuclide therapy): radioimmunotherapy and peptide receptor radionuclide therapy) that any one has a special function in cancerous cells destroy. Results: Chemotherapy has still its place in cancer treatment and is used as a current and worldwide method. Nowadays, radiation therapy evolves with a surprising growth. By abandoning Cobalt-60, linear and circular accelerators which are able to accelerate particles, could be used for cancer treatment. CyberKnife, IMRT, IGRT, SBRT, VMAT, tomotherapy and Vero are the most advanced methods used to radiation therapy in all angles which had minimum mistake in radiation to the near intact tissues. Today, brachytherapy by increasing production of treatment radioisotopes by cyclotron and reactor is used in the world. Endoradiotherapy (Target radionuclide therapy): Radioimmunotherapy and peptidereceptor radionuclide therapy are two considerable methods in cancer treatment. Conclusion: In this review, we consider principals and application of radiation therapy in the early 21st century.
- 7 October 2011
- Published by Pleiades Publishing Ltd in Radiochemistry
- Vol. 53 (5) , 539-544
Production and radiochemical separation of no-carrier-added 88Y by liquid-liquid extraction
A method was suggested for the cyclotron production of 88Y with liquid-liquid extraction. The sedimented natSrCO3 target was irradiated with 18-MeV protons at current of 20 μA for 10 h. The 88Y yields of about 1.326 MBq μA−1 h−1 were experimentally obtained. Solvent extraction of no-carrier-added 88Y from irradiated strontium carbonate target in the hydrochloric acid solution was studied using di(2-ethylhexyl) hydrogen phosphate (HDEHP). The optimum separation was achieved in the system n-hexane/10% HDEHP-0.1 M HCl. Yttrium radionuclides were recovered from the HDEHP phase by stripping with 60 ml of 9 M HC1. Also, excitation functions of the proton, deuteron, and α-particle induced reactions of 89Y, 88Sr, natSr, and natRb were determined using computer codes and compared to the existing data.
- 7 October 2011
- Published by Pleiades Publishing Ltd in Radiochemistry
- Vol. 53 (5) , 539-544
Production and radiochemical separation of no-carrier-added 88Y by liquid-liquid extraction
A method was suggested for the cyclotron production of 88Y with liquid-liquid extraction. The sedimented natSrCO3 target was irradiated with 18-MeV protons at current of 20 μA for 10 h. The 88Y yields of about 1.326 MBq μA−1 h−1 were experimentally obtained. Solvent extraction of no-carrier-added 88Y from irradiated strontium carbonate target in the hydrochloric acid solution was studied using di(2-ethylhexyl) hydrogen phosphate (HDEHP). The optimum separation was achieved in the system n-hexane/10% HDEHP-0.1 M HCl. Yttrium radionuclides were recovered from the HDEHP phase by stripping with 60 ml of 9 M HC1. Also, excitation functions of the proton, deuteron, and α-particle induced reactions of 89Y, 88Sr, natSr, and natRb were determined using computer codes and compared to the existing data.
- 1 October 2011
- Published by Elsevier in Annals of Nuclear Energy
- Vol. 38 (10) , 2168-2173
Investigation of palladium-103 production and IR07-103Pd brachytherapy seed preparation
- 1 October 2011
- Published by Elsevier in Annals of Nuclear Energy
- Vol. 38 (10) , 2168-2173
Investigation of palladium-103 production and IR07-103Pd brachytherapy seed preparation
- 18 August 2011
- Published by Pleiades Publishing Ltd in Radiochemistry
- Vol. 53 (4) , 411-414
45Ti, a candidate for positron emission tomography: Study of the cyclotron production
The nuclear-physical properties of 45Ti (half-life 3.08 h, 85% β+-decay, 15% electron capture, daughter isotope 45Sc) make it suitable for positron emission tomography. 45Ti can be produced at a small cyclotron in a high yield, 450 MBq μA−1 h−1, using the 45Sc(p,n)45Ti nuclear reaction on a natural scandium target. The excitation functions for the 45Sc(p,n)45Ti reaction were calculated by ALICE/91, ALICE/ASH, and TALYS-1.2 codes and compared to the existing data. Deposition of Sc2O3 on a Cu substrate was carried out by two sedimentation methods for the production of 45Ti, and a simple method for radiochemical separation of radiotitanium was suggested. The targets were examined by SEM and subjected to thermal shock test. The optimal thicknesses of target was substantiated, and the production yield for the 45Sc(p,n)45Ti reaction was calculated.
- 18 August 2011
- Published by Pleiades Publishing Ltd in Radiochemistry
- Vol. 53 (4) , 411-414
45Ti, a candidate for positron emission tomography: Study of the cyclotron production
The nuclear-physical properties of 45Ti (half-life 3.08 h, 85% β+-decay, 15% electron capture, daughter isotope 45Sc) make it suitable for positron emission tomography. 45Ti can be produced at a small cyclotron in a high yield, 450 MBq μA−1 h−1, using the 45Sc(p,n)45Ti nuclear reaction on a natural scandium target. The excitation functions for the 45Sc(p,n)45Ti reaction were calculated by ALICE/91, ALICE/ASH, and TALYS-1.2 codes and compared to the existing data. Deposition of Sc2O3 on a Cu substrate was carried out by two sedimentation methods for the production of 45Ti, and a simple method for radiochemical separation of radiotitanium was suggested. The targets were examined by SEM and subjected to thermal shock test. The optimal thicknesses of target was substantiated, and the production yield for the 45Sc(p,n)45Ti reaction was calculated.